U.S. market Closed. Opens in 1 hour 18 minutes

UBX | Unity Biotechnology, Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 1.1400 - 1.1800
52 Week Range 1.1050 - 2.1700
Beta 1.27
Implied Volatility 262.46%
IV Rank 54.01%
Day's Volume 52,827
Average Volume 50,909
Shares Outstanding 16,850,400
Market Cap 19,714,968
Sector Healthcare
Industry Biotechnology
IPO Date 2018-05-03
Valuation
Profitability
Growth
Health
P/E Ratio -0.91
Forward P/E Ratio N/A
EPS -1.28
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 19
Country USA
Website UBX
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular degeneration, and diabetic retinopathy. It also develops UBX1967 for the treatment of ophthalmologic diseases; UBX2050, a human anti-Tie2 agonist monoclonal antibody for the treatment of age-related eye diseases; and UBX2089, a a-Klotho hormone drug candidate for multiple neurology indications. The company was formerly known as Forge, Inc. and changed its name to Unity Biotechnology, Inc. in January 2015. Unity Biotechnology, Inc. was incorporated in 2009 and is headquartered in South San Francisco, California.
*Chart delayed
Analyzing fundamentals for UBX we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is on medium level and Health is very weak. For more detailed analysis please see UBX Fundamentals page.

Watching at UBX technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on UBX Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙